Journal Title：Rheumatology International

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.

RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

《風濕病學國際》是一本獨立雜志，反映全球各種風濕病研究、診斷和治療的進展。它旨在為風濕病學領域的研究人員和臨床醫(yī)生服務。

《風濕病學國際》將涵蓋臨床研究以及風濕病管理的所有現代趨勢。將特別強調與風濕病相關的公共衛(wèi)生問題、將風濕病研究應用于臨床實踐、風濕病流行病學、風濕病診斷測試、風濕病患者報告結果 (PRO) 以及風濕病教育證據。這些主題的貢獻將以原始出版物、簡短通訊、社論和評論的形式出現。歡迎“致編輯的信”，以增強討論。我們不鼓勵提交基礎科學研究，包括體外或動物研究，因為我們只會從流行病學或臨床的角度審查人類研究。未經適當文獻審查的病例報告（基于病例的審查）將不予發(fā)表。我們將盡一切努力確保出版速度，同時保持高標準的內容和制作。

提交出版的手稿必須包含一份聲明，說明所有人類研究均已由適當的倫理委員會審查，因此已按照 1964 年《赫爾辛基宣言》適當版本規(guī)定的道德標準進行。文中還應明確說明，所有人在參與研究之前均已知情同意。應省略可能泄露研究對象身份的細節(jié)。

Rheumatology International創(chuàng)刊于1981年，由Springer Berlin Heidelberg出版商出版，收稿方向涵蓋醫(yī)學 - 風濕病學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約16.月 ，影響因子指數3.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。